Evidence map›Paper›PMID 40681719›Full record

ArticleScientific reports2025

Machine learning framework for oxytetracycline removal using nanostructured cupric oxide supported on magnetic chitosan alginate biocomposite.

Hassan Rasoulzadeh, Hossein Azarpira, Mojtaba Pourakbar, Amir Sheikhmohammadi, Alieh Rezagholizade-Shirvan

RetractedAbstract readRetracted Publication
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Hassan RasoulzadehDepartment of Environmental Health Engineering, Maragheh University of Medical Sciences, Maragheh, Iran.
Hossein AzarpiraDepartment of Environmental Health Engineering, Social Determinants of Health Research Center, Saveh University of Medical Sciences, Saveh, Iran.
Mojtaba PourakbarDepartment of Environmental Health Engineering, Maragheh University of Medical Sciences, Maragheh, Iran.
Amir SheikhmohammadiDepartment of Environmental Health, School of Public Health, Khoy University of Medical Sciences, Khoy, Iran. asheikh1359@gmail.com.
Alieh Rezagholizade-ShirvanDepartment of Food Science and Technology, Neyshabur University of Medical Sciences, Neyshabur, Iran. alie.gholizade@gmail.com.

Funding

Maragheh University of Medical Sciences 403000010
6 · The paper itself

Abstract

This research proposes a machine learning controlled method for removing the antibiotic oxytetracycline (OTC) from liquids through the use of nanostructured cupric oxide (CuO) nanoparticles. These nanoparticles are attached to magnetic chitosan/alginate biocomposites (CuO-M-CAB). The dataset consisted of 42 experimentally generated samples, systematically created using key parameters (X1: antibiotic concentration, X2: pH, X3: reaction time, and X4: adsorbent concentration). Prior to applying machine learning models, preprocessing steps were performed, including normalization using Min-Max Scaling to confine all features within the [0,1] range, outlier detection and removal of anomalous values, correlation analysis to avoid redundancy and multicollinearity, and data splitting into training and testing sets at an 80:20 ratio, along with K-fold cross-validation (k = 5) for robust model evaluation. The study assesses the accurate predictions of specific models, including Tikhonov Regularization, Yandex Boosting, and Particle Swarm Optimization (PSO), to improve removal efficiency and provide analysis of the components influencing the method. The Tikhonov model demonstrates high accuracy with R

Indexed as

AlginatesAnti-Bacterial AgentsChitosanCopperMachine LearningNanostructuresOxytetracyclineAdsorptionAlginatesAnti-Bacterial AgentsChitosanCoppercupric oxideOxytetracyclineAqueous solution treatmentMachine learning frameworkMagnetic chitosanNanostructured cupric oxideOxytetracycline removal

Identifiers

PMID40681719
PMCPMC12274579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.